Pricing Log in Create free account

GENPREX (GNPX) vs Silo Pharma, Inc. (SILO)

GENPREX and Silo Pharma, Inc. are both Biotechnology companies. GENPREX and Silo Pharma, Inc. are of similar size ($1.9M and $1.9M). Silo Pharma, Inc. has negative trailing earnings, so its P/E is not meaningful; GENPREX trades at 0.0×. Across the 10 metrics below, GENPREX leads on 6 and Silo Pharma, Inc. on 4.

Valuation

Metric GNPX SILO Biotechnology median
P/E 0.03 n/m 8.50
P/S n/m 18.00 9.71
P/B 0.07 0.27 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.89 0.90 0.64
EV/Sales n/m (54.56) 9.21
Earnings yield 3,170.61% (369.34%) (33.15%)
Free cash flow yield (1,481.72%) (302.55%) (25.50%)

Profitability

Metric GNPX SILO Biotechnology median
Gross margin 0.00% 11.81% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (203.86%) (91.23%) (56.36%)
Return on assets (157.40%) (70.96%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GNPX SILO Biotechnology median
Revenue growth (TTM) — 0.00% 6.02%
EPS growth (last fiscal year) 93.48% 57.98% 30.26%
Revenue growth, 5-year CAGR — 12.17% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNPX SILO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.76 5.36 4.72
Net debt to EBITDA 0.50 1.61 0.96

Dividend

Metric GNPX SILO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GNPX SILO Biotechnology median
Market cap 1.88m 1.91m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack